STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments

Also Read

• Texas Democrats Capture Statewide Offices, Confronting Urgent Healthcare Reform
• Johnson & Johnson’s Rybrevant Faspro Gains Accelerated FDA Nod for Head and Neck Squamous Cell Carcinoma
• Readers Respond: Autism Diagnosis, Masking Research, and the Limits of Labels
• Booze, Tobacco Together in Pregnancy May Worsen Baby’s Facial Abnormalities